Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial.

An innovative approach to address a clinical question for a rare event in an orphan disease, cystic fibrosis, is presented to enhance current clinical evidence to guide cystic fibrosis care in relation to new MRSA infection.